Search Beyond News…

GMP secures AstraZeneca’s Madrid office complex, bolstering its office portfolio amid rising corporate HQ interest in the city

Executive summary: GMP bought AstraZeneca’s Madrid office complex (20,000 sqm) in Las Tablas for an undisclosed sum. The acquisition expands GMP’s office holdings in a prime Madrid submarket and signals confidence in sustained demand for corporate office space despite high household living costs.

Who is involved: GMP (Socimi), AstraZeneca (seller), Madrid local market, and other firms eyeing relocations such as Changan and JetBrains.

Likely next: GMP may seek tenants or reposition the asset; further office transactions could follow as more companies announce Madrid HQ plans.

The Socimi GMP announced the purchase of AstraZeneca’s former headquarters in Las Tablas, Madrid, a 20,000‑square‑meter office complex. The deal adds prime office space to GMP’s portfolio and reflects continued demand for quality office assets in the Spanish capital. The transaction occurs as several firms, including Changan and JetBrains, announce plans to expand or relocate their European operations to Madrid. While housing costs are consuming a large share of household budgets, the office market remains active, suggesting divergent pressures across real estate segments.

Timeline

Analysis — what this means

Likely next events

Sectors affected

Regulatory implications

Historical parallels

Key entities

Sources

Related cases

Browse the full archive →